Oragenics, Inc. (OGEN) DCF Valuation

Valoración de DCF de Oragenics, Inc. (OGEN)

US | Healthcare | Biotechnology | AMEX
Oragenics, Inc. (OGEN) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Oragenics, Inc. (OGEN) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¿Busca determinar el valor intrínseco de la Oragenics, Inc.? Nuestra calculadora DCF (OGEN) integra datos del mundo real con extensas características de personalización, lo que le permite refinar sus pronósticos y mejorar sus opciones de inversión.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .1 .1 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 51.2 -71.37 -5.04 -5.04 -5.04 -5.04 -5.04
EBITDA -15.5 -26.4 -15.7 -14.2 -20.9 .0 .0 .0 .0 .0
EBITDA, % 100 100 -17996.51 -10818.52 -55447.14 -20 -20 -20 -20 -20
Depreciation .1 .1 .0 .0 .0 .0 .0 .0 .0 .0
Depreciation, % 100 100 47.41 33.96 72.75 70.82 70.82 70.82 70.82 70.82
EBIT -15.6 -26.4 -15.7 -14.3 -20.9 .0 .0 .0 .0 .0
EBIT, % 100 100 -18043.91 -10852.48 -55519.89 -20 -20 -20 -20 -20
Total Cash 18.3 17.6 27.3 11.4 3.5 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 8.03 0 0
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 0 0 0 40 40 40 40 40
Accounts Payable 1.2 .3 .9 .2 1.2 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 982.89 187.57 3306.37 100 100 100 100 100
Capital Expenditure .0 .0 .0 -.1 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 -50.44 -96.96 0 -29.48 -29.48 -29.48 -29.48 -29.48
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -15.6 -26.4 -15.7 -14.1 -20.9 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -14.3 -27.3 -15.2 -14.8 -19.9 -1.2 .0 .0 .0 .0
WACC, % 6.18 6.18 6.18 6.17 6.18 6.17 6.17 6.17 6.17 6.17
PV UFCF
SUM PV UFCF -1.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -3
Equity Value 2
Diluted Shares Outstanding, MM 2
Equity Value Per Share 0.95

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real OGEN financials.
  • Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe the effect of your inputs on Oragenics’ valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • Advanced DCF Calculator: Features comprehensive unlevered and levered DCF valuation models tailored for Oragenics, Inc. (OGEN).
  • WACC Calculator: Comes with a pre-built Weighted Average Cost of Capital sheet that allows for customizable inputs specific to Oragenics, Inc. (OGEN).
  • Editable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates according to your analysis needs for Oragenics, Inc. (OGEN).
  • Built-In Financial Ratios: Evaluate profitability, leverage, and efficiency ratios relevant to Oragenics, Inc. (OGEN).
  • Dashboard and Charts: Visual representations summarize essential valuation metrics for straightforward analysis of Oragenics, Inc. (OGEN).

How It Works

  1. Download the Template: Get instant access to the Excel-based OGEN DCF Calculator.
  2. Input Your Assumptions: Adjust yellow-highlighted cells for growth rates, WACC, margins, and more.
  3. Instant Calculations: The model automatically updates Oragenics’ intrinsic value.
  4. Test Scenarios: Simulate different assumptions to evaluate potential valuation changes.
  5. Analyze and Decide: Use the results to guide your investment or financial analysis.

Why Choose This Calculator for Oragenics, Inc. (OGEN)?

  • All-in-One Solution: Combines DCF, WACC, and financial ratio assessments tailored for Oragenics.
  • Flexible Inputs: Modify yellow-highlighted cells to explore different financial scenarios for OGEN.
  • In-Depth Analysis: Automatically computes Oragenics’ intrinsic value and Net Present Value.
  • Preloaded Information: Historical and projected data provide reliable starting points for analysis.
  • High-Quality Standards: Perfect for financial analysts, investors, and business consultants focused on OGEN.

Who Should Use This Product?

  • Investors: Assess Oragenics, Inc.'s (OGEN) valuation prior to making investment decisions.
  • CFOs and Financial Analysts: Optimize valuation methodologies and evaluate financial forecasts.
  • Startup Founders: Discover the valuation strategies employed by established companies like Oragenics, Inc.
  • Consultants: Create detailed valuation reports to assist clients in their financial planning.
  • Students and Educators: Utilize real-time data to enhance learning and apply valuation concepts.

What the Template Contains

  • Pre-Filled Data: Includes Oragenics, Inc.'s historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze Oragenics, Inc.'s profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.